Earnings History Data for CARISMA THERAP (CARM) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

CARISMA THERAP

Carisma Therapeutics Inc. is a late-stage clinical company which focused on advancing targeted fusion protein therapeutics for the treatment of patients with cancer. The company's advanced product candidate includes Vicineum(TM). Carisma Therapeutics Inc., formerly known as Sesen Bio Inc., is based in CAMBRIDGE, Mass.

Release Date	Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
09-11-2023	PM	CARM	CARISMA THERAP	132.00	-0.53	-0.60	0.00	Sesen Bio GAAP EPS of -$0.53 beats by $0.04, revenue of $3.83M beats by $2.94M [11/9/2023 7:47 AM]	2.65	-0.33 (-11.07%)	0.0	0.0 (0.00%)	2.62 - 9.77	77,602	150,000	0
Sesen Bio GAAP EPS of -$0.53 beats by $0.04, revenue of $3.83M beats by $2.94M [11/9/2023 7:47 AM]
10-08-2023	PM	CARM	CARISMA THERAP	225.00	-0.49	-0.66	0.00	Sesen Bio GAAP EPS of -$0.49 beats by $0.11, revenue of $3.56M beats by $2.75M [8/10/2023 11:08 AM]	5.93	0.34 (6.17%)	0.0	0.0 (0.00%)	2.75 - 9.77	138,955	270,000	0
Sesen Bio GAAP EPS of -$0.49 beats by $0.11, revenue of $3.56M beats by $2.75M [8/10/2023 11:08 AM]